514 related articles for article (PubMed ID: 35507586)
1. Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China.
Shi M; Lin J; Wei W; Qin Y; Meng S; Chen X; Li Y; Chen R; Yuan Z; Qin Y; Huang J; Liang B; Liao Y; Ye L; Liang H; Xie Z; Jiang J
PLoS Negl Trop Dis; 2022 May; 16(5):e0010388. PubMed ID: 35507586
[TBL] [Abstract][Full Text] [Related]
2. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study.
Jiang J; Meng S; Huang S; Ruan Y; Lu X; Li JZ; Wu N; Huang J; Xie Z; Liang B; Deng J; Zhou B; Chen X; Ning C; Liao Y; Wei W; Lai J; Ye L; Wu F; Liang H
Clin Microbiol Infect; 2019 Feb; 25(2):233-241. PubMed ID: 29698815
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and risk factors for readmission in HIV-infected patients with Talaromyces marneffei infection.
Shi M; Qin Y; Chen S; Wei W; Meng S; Chen X; Li J; Li Y; Chen R; Su J; Yuan Z; Wang G; Qin Y; Ye L; Liang H; Xie Z; Jiang J
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011622. PubMed ID: 37816066
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model.
Cen J; Huang J; Zeng W; Pan M; Qiu Y; Zhang J
Heliyon; 2023 Sep; 9(9):e20068. PubMed ID: 37809964
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Prognosis of Talaromyces marneffei Infection in HIV-positive Children in Southern China.
Xue X; Zou J; Fang W; Liu X; Chen M; Arastehfar A; Ilkit M; Zheng Y; Qin J; Peng Z; Hu D; Liao W; Pan W
Mycopathologia; 2022 Jun; 187(2-3):169-180. PubMed ID: 35157189
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics of HIV-Associated Talaromyces marneffei Infection of Intestine in Southern China.
Xie Z; Lai J; Peng R; Mou M; Liang H; Ning C
Int J Infect Dis; 2022 Jul; 120():48-50. PubMed ID: 35398298
[TBL] [Abstract][Full Text] [Related]
7. Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome.
Chen X; Ou X; Wang H; Li L; Guo P; Chen X; Cai W; Tang X; Li L
Mycopathologia; 2022 Jun; 187(2-3):205-215. PubMed ID: 35237935
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio and lactate dehydrogenase for early diagnosis of AIDS patients with Talaromyces marneffei infection.
Huang JL; Zhou XX; Luo P; Lu XY; Liang LH; Lan GB; Chen L; Lin FQ
Ann Palliat Med; 2022 Feb; 11(2):588-597. PubMed ID: 35249337
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection.
Sun J; Sun W; Tang Y; Zhang R; Liu L; Shen Y; Wang J; Chen J; Qi T; Wang Z; Song W; Lin Y; Xu S; Lu H
BMC Infect Dis; 2021 Jun; 21(1):514. PubMed ID: 34074256
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the risk of cytopenia in hospitalized HIV/AIDS patients using machine learning methods based on electronic medical records.
Huang L; Xie B; Zhang K; Xu Y; Su L; Lv Y; Lu Y; Qin J; Pang X; Qiu H; Li L; Wei X; Huang K; Meng Z; Hu Y; Lv J
Front Public Health; 2023; 11():1184831. PubMed ID: 37575113
[TBL] [Abstract][Full Text] [Related]
11. The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis.
Guo P; Chen W; Chen S; Chen M; Hu F; Chen X; Cai W; Tang X; Li L
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011201. PubMed ID: 37011093
[TBL] [Abstract][Full Text] [Related]
12. Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.
Ying RS; Le T; Cai WP; Li YR; Luo CB; Cao Y; Wen CY; Wang SG; Ou X; Chen WS; Chen SZ; Guo PL; Chen M; Guo Y; Tang XP; Li LH
HIV Med; 2020 Dec; 21(11):729-738. PubMed ID: 33369035
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: A retrospective study in southern China.
Wang Y; Mo X; Zhang J; Yan Z; Fang Y; Deng W; Xu J; Peng J; Miao Y
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37553136
[TBL] [Abstract][Full Text] [Related]
14. Application of machine learning model in predicting the likelihood of blood transfusion after hip fracture surgery.
Chen X; Pan J; Li Y; Tang R
Aging Clin Exp Res; 2023 Nov; 35(11):2643-2656. PubMed ID: 37733228
[TBL] [Abstract][Full Text] [Related]
15. Case report: Diagnosis of
Du R; Feng Y; Mao H
Front Cell Infect Microbiol; 2023; 13():1163846. PubMed ID: 37469600
[TBL] [Abstract][Full Text] [Related]
16. Effects of cotrimoxazole prophylaxis on
Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H
Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
[TBL] [Abstract][Full Text] [Related]
17. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases.
Zeng Q; Jin Y; Yin G; Yang D; Li W; Shi T; Lu G; Huang L; Fan H
BMC Infect Dis; 2021 Mar; 21(1):287. PubMed ID: 33743629
[TBL] [Abstract][Full Text] [Related]
18. Talaromyces marneffei infection in non-HIV-infected patients in mainland China.
He L; Mei X; Lu S; Ma J; Hu Y; Mo D; Chen X; Fan R; Xi L; Xie T
Mycoses; 2021 Oct; 64(10):1170-1176. PubMed ID: 34110649
[TBL] [Abstract][Full Text] [Related]
19. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis.
Qin Y; Huang X; Chen H; Liu X; Li Y; Hou J; Li A; Yan X; Chen Y
BMC Infect Dis; 2020 Jul; 20(1):551. PubMed ID: 32727383
[TBL] [Abstract][Full Text] [Related]
20. A Reliable Murine Model of Disseminated Infection Induced by Talaromyces Marneffei.
He J; Li JS; Xu HY; Kuang YQ; Li J; Li HB; Li Z; Zhou HL; Wang RR; Li YY
Mycopathologia; 2022 Feb; 187(1):53-64. PubMed ID: 34743276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
